ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
NovoCure Ltd

NovoCure Ltd (NVCR)

30,70
-1,20
(-3,76%)
Fermé 29 Décembre 10:00PM
30,70
0,01
(0,03%)
Après les heures de négociation: 1:50AM
Graphique avancé

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
30,70
Prix Achat
28,55
Prix Vente
38,00
Volume échangé
561 286
30,38 Fourchette du Jour 32,055
11,70 Plage de 52 semaines 34,13
Cap du marché
Clôture Veille
31,90
Ouverture
31,74
Dernière Transaction
14
@
30.21
Dernière heure de transaction
Volume financier
US$ 17 334 674
VWAP
30,8839
Volume moyen (3 m)
1 368 756
Actions en circulation
108 201 434
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-16,04
Bénéfice par action (BPA)
-1,91
Chiffre d'affairess
509,34M
Bénéfice net
-207,04M

À propos de NovoCure Ltd

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives it... NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
Siège social
Jersey, Gbr
Fondé
-
NovoCure Ltd est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker NVCR. Le dernier cours de clôture d'NovoCure était de US$31,90. Au cours de la dernière année, les actions de NovoCure ont été négociées dans une fourchette de prix de US$ 11,70 à US$ 34,13.

NovoCure compte actuellement 108 201 434 actions en circulation. La capitalisation boursière d'NovoCure est de US$3,45 milliard. NovoCure a un ratio cours/bénéfice (ratio PE) de -16.04.

NVCR Dernières nouvelles

Novocure annonce des résultats positifs de l'essai clinique de phase 3 PANOVA-3 sur les champs de traitement des tumeurs (TTFields) pour le cancer du pancréas

PANOVA-3 a atteint son objectif principal avec une amélioration statistiquement importante de la survie globale des patients atteints d'un adénocarcinome pancréatique non résécable et localement...

ノボキュア、膵がんに対する腫瘍治療電場療法(TTフィールド)の第3相臨床試験PANOVA-3のトップライン結果を発表

PANOVA-3試験でゲムシタビンおよびnab-パクリタキセルと併用したTTフィールドを一次治療として用いた切除不能な局所進行膵腺がん患者の全生存期間が統計的に有意に改善、主要評価項目を達成 アメリカ、EU、日本...

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

PANOVA-3 met its primary endpoint with a statistically significant improvement in overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma treated in the...

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

PANOVA-3 met its primary endpoint with a statistically significant improvement in overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma treated in the first...

Novocure to Participate in Upcoming Investor Conferences

Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor conferences: Evercore ISI HealthCONx Conference on Wednesday, December 4, 2024, in Coral Gables...

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

Novocure (NASDAQ: NVCR) announced today that it will present new data for its Tumor Treating Fields (TTFields) therapy for glioblastoma at the 29th Annual Scientific Meeting and Education Day of...

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

New flexible arrays are lighter, thinner and designed to improve comfort for Optune Gio users Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.2350.77137698998930.46531.9929.8185011630.97643141CS
410.8454.582074521719.8634.1319.575192794329.96425812CS
1215.65103.98671096315.0534.1314.17136875622.97595724CS
2612.6670.17738359218.0434.1314.17132006820.37748223CS
5217124.08759124113.734.1311.7132626118.28459878CS
156-53.3-63.452380952484120.0310.87109707438.16840661CS
260-56.85-64.934323243987.55232.7610.87101016067.02949891CS

NVCR - Frequently Asked Questions (FAQ)

What is the current NovoCure share price?
The current share price of NovoCure is US$ 30,70
How many NovoCure shares are in issue?
NovoCure has 108 201 434 shares in issue
What is the market cap of NovoCure?
The market capitalisation of NovoCure is USD 3,45B
What is the 1 year trading range for NovoCure share price?
NovoCure has traded in the range of US$ 11,70 to US$ 34,13 during the past year
What is the PE ratio of NovoCure?
The price to earnings ratio of NovoCure is -16,04
What is the cash to sales ratio of NovoCure?
The cash to sales ratio of NovoCure is 6,52
What is the reporting currency for NovoCure?
NovoCure reports financial results in USD
What is the latest annual turnover for NovoCure?
The latest annual turnover of NovoCure is USD 509,34M
What is the latest annual profit for NovoCure?
The latest annual profit of NovoCure is USD -207,04M
What is the registered address of NovoCure?
The registered address for NovoCure is NO 4 THE FORUM, GRENVILLE STREET, ST. HELIER, JERSEY, JE2 4UF
What is the NovoCure website address?
The website address for NovoCure is www.novocure.com
Which industry sector does NovoCure operate in?
NovoCure operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
189,59M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,79M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
131,98M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
936,47k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,31M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
926,19k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,26M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,11M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
305,79M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
268M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
256,01M

NVCR Bilan

Bilan
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock